Pathway Pharmacy (Avenue Pharmacy, Inc.), Ocala, FL
Is Pathway Pharmacy (Avenue Pharmacy, Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Pathway Pharmacy (Avenue Pharmacy, Inc.) hold a Florida pharmacy license?
The Florida Board of Pharmacy lists 2 licenses for this name and city, as of Nov 15, 2026: PH26742 for AVENUE PHARMACY INC (dba PATHWAY PHARMACY), OCALA, status Clear and PH31346 for Pathway Pharmacy, LLC (dba Pathway Pharmacy), OCALA, status Vol Relinquish. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054021824 for AVENUE PHARMACY INC, OCALA, FL, status NOT RENEWED, as of Nov 13, 2026.
Has Pathway Pharmacy (Avenue Pharmacy, Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 FMD-145 letter (Jun 4, 2025) for Pathway Pharmacy (Avenue Pharmacy, Inc.). State board actions: no Florida Board of Pharmacy action on licenses PH26742 and PH31346 or under this exact name and city was found in the board’s enforcement list for pharmacy permits (actions dated Sep 19, 1980 to Nov 10, 2026) on Nov 15, 2026.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Avenue Pharmacy, Inc.; Pathway Pharmacy
- Location
- Ocala, FL
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 2
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Jun 4, 2025
- FDA Data Dashboard inspections
- 3 inspections: 2 OAI, 1 VAI; 3 published Form 483s
- Form 483 text on this page
- 1 Form 483, 2 observations
- State board records
- License found: PH26742, Clear; PH31346, Vol Relinquish
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Avenue Pharmacy, Inc., (dba Pathway Pharmacy), a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Jun 4, 2025 | FMD-145 letter | FMD-145 Letter Issued 06/04/2025 | Not linked by FDA |
| Oct 4, 2024 | Form 483 | 483 Issued 10/04/2024 | FDA copy (archived) |
| Dec 6, 2019 | Form 483 | 483 Issued 12/06/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Avenue Pharmacy Inc, Ocala, FL (FEI number 3010810839), matched to this page by exact name, city and state. It lists 3 inspections: 2 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Oct 4, 2024 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3010810839 | 1250883 |
| Jun 22, 2021 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3010810839 | 1144449 |
| Dec 6, 2019 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3010810839 | 1113074 |
Form 483s FDA has published for this site
- Oct 4, 2024: Form 483 to Avenue Pharmacy Inc, published Nov 6, 2024. fda.gov
- Jul 23, 2015: Form 483 to Avenue Pharmacy Inc, published Jan 17, 2024. fda.gov
- Jul 10, 2015: Form 483 to Avenue Pharmacy Inc, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Oct 1, 2024 to Oct 4, 2024: 2 observations
- Firm on the cover
- Avenue Pharmacy Inc dba Pathway Pharmacy, 202 Sw 17th St Ste A, Ocala, FL 34471-8138
- FEI number
- 3010810839
- Establishment type on the cover
- Producer of Non-Sterile Drug Products
- FDA district office on the cover
- 555 Winderley Place, Suite 200 Maitland, FL 32751
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.
Specifically,
I. Your firm's contract testing laboratory identified five potency failures specifically <Redacted B4> for the following finished drug product and bulk lots which were used in the production of finished drug product batches. Testosterone 2mg/mL cream lot# 06102024® <Redacted B4> (produced on 6/10/24) = 85.5%, BUD: 12/7/24 was dispensed to a patient on <Redacted B4>. Liothyronine (T3) bulk lot #0612202LI-~ = 77.3% (produced on 6/12/24), BUD: 12/9/24. This bulk product was used to produce <Redacted B4> finished product lots that were dispensed to patients. Levothyroxine (T4) bulk lot #06032024@0= 121.8% (produced on 6/3/24), BUD: 11/30/24. This bulk product was used to produce <Redacted B4> finished product lots that were dispensed to patients. Levothyroxine (T4) bulk lot #04172024~ <Redacted B4> 148.3% (produced on 4/17/24), BUD: 10/14/24. This bulk product was used to produce ><Redacted B4> finished product lots that were dispensed to patients. ...
Observation 2
Contamination was observed in your production area and areas adjacent to production areas.
Specifically,
I. On 10/1/24, I observed <Redacted B4> AC units within your firm's Hazardous Room that contain white powder residue and dust which could potentially lead to product contamination. Your pharmacy technician had an open container of Testosterone Cream, 4mg/g, lot #09302024@0 BUD: 12/29/24 on the countertop adjacent to <Redacted B4> AC unit. In addition, white powder residue was observed on ALL surfaces (refrigerator, countertops, Bulk Drug Substance containers, etc.) of your Hazardous Room.
Ko) I
2. Your pharmacy technician was observed placing her soiled gloved index finger inside of the finished product Testosterone Cream, 4mg/g, lot #09302024@ <Redacted B4> BUD: 12/29/24 to remove residual product from the container.
3 .On 10/1/24 and 10/2/24, I observed a blue ripped towel which appears un-clean in the hazardous hood. Your pharmacy technician stated she uses the towel to wipe her gloved hands and powder accumulation within the hood.
hood. Your pha1macy technician stated she uses the towel to wipe her gloved hands and powder accumulation within the hood.
4. ...
Linked 483s whose text is not shown
- Dec 6, 2019: FDA document 134266: its numbered observations could not be read reliably from the PDF text.
- Jul 23, 2015: FDA document 90258: the PDF is a scanned image with no readable text.
- Jul 10, 2015: FDA document 88877: the FEI number and firm name on its cover do not match this page by the rule.
State board of pharmacy records
The Florida Board of Pharmacy file dated Nov 15, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| PH26742 | Pharmacy | AVENUE PHARMACY INC (dba PATHWAY PHARMACY) | OCALA | Clear |
| PH31346 | Pharmacy | Pathway Pharmacy, LLC (dba Pathway Pharmacy) | OCALA | Vol Relinquish |
What this covers: Every enforcement action the Florida Department of Health lists for Board of Pharmacy pharmacy permits, worded as the department gives it. The list includes administrative complaints filed as well as final actions, and links no documents. An administrative complaint is an allegation the department has filed, not a finding. Actions in the data are dated Sep 19, 1980 to Nov 10, 2026.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054021824 | LICENSED PHARMACY | AVENUE PHARMACY INC | OCALA, FL | NOT RENEWED |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Florida Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Florida Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.